Celixir (previously trading as Cell Therapy) is a British pioneer in Regenerative Medicine. Its team of scientists and biotechnology leadership is devoted to discovering breakthrough medicines that aim to change the standard of medical care for patients.

  • Amount raised (£)

    £689,246

  • Company number

    06970743

  • Incorporation date

    23/07/2009

  • Total investors

    297

Details

  • Company number

    06970743

  • Incorporation date

    23/07/2009

  • Company status

    Active

  • Industry type

    Other research and experimental development on natural sciences and engineering

  • Number of current appointments

    2

Celixir House Stratford-Upon-Avon Business & Technology Park
Innovation Way
Stratford-Upon-Avon
CV37 7GZ

Crowdcube Funding History

Date Amount No. of Investors
01/12/2014 £689,246 297 View

Key Financials

View all financials
2019 2020
Turnover £765.11k £664.32k
Cash £1.79m £871.87k
Increase in Cash - -

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Date Description Type
08/08/2022

Confirmation statement made on 2022-07-27 with no updates

PDF
13/06/2022

Accounts for a small company made up to 2022-03-31

PDF
16/05/2022

Director's details changed for Celixir Plc on 2021-01-22

PDF

People

Name Role Appointed Nationality
REGINALD, Ajan Director 21/07/2021 British
CELIXIR LIMITED Corporate-director 19/01/2019